4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-049790
Chief Executive Officer sold 35,452 shares at an average $94.92 ($3,365,010)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BELANOFF JOSEPH K · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-31 | Sale : show line 1 in the form 10b5-1 | −35,102 | $94.72 | $3,324,861 | 2,982,335 | I |
| 2025-04-01 | Sale : show line 2 in the form 10b5-1 | −350 | $114.71 | $40,149 | 2,981,985 | I |
| Open-market sales · 35,452 sh · avg $94.92 · $3,365,010 | ||||||
Loading xslF345X05/ownership.xml…